Phosphoinositide 3-kinase p110gamma human, >=95% (SDS-PAGE), recombinant, expressed in baculovirus i

Stock Code: 3592033
Manufacturer Part No: P8615-10UG

Order Now for 7 day delivery

Click Add to Quote for price and delivery

Quantity: - +

Descriptions

Biochem/physiol Actions

PI 3-kinases have been implicated in diverse cellular responses triggered by mammalian cell surface receptors. Inhibits NF-κB, AP-1, and STAT1α mediated gene expression induced by IFN-γ resulting in inhibition of COX-2 and NOS ll (iNOS) expression.

Phosphatidylinositol 3-kinase p110? is implicated in the development of eosinophilic inflammation. Thus, inhibition of PI3K? expression can be considered as a potential therapeutic method for treating eosinophil-related diseases, including asthma. Knockdown of PIK3CG gene inhibits the PI3K-Akt/PKB signaling pathway, which is essential for tumorigenesis and the progression of colorectal cancers. Mutation in the gene is associated with the development of autistic disorder.

General description

Phosphatidylinositol 3-kinase p110? /phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit ? (PIK3CG) gene, with 12 exons spanning 43kb on genomic DNA, is mapped to human chromosome 7q22.3. PIK3CG belongs to the family of genes coding for enzymes that phosphorylate the 3?-hydroxyl of phosphatidylinositol.

Physical form

Solution in 10 mM HEPES, pH 7.5, 100 mM NaCl, 0.5 mM MgCl2, 50% glycerol.

Unit Definition

1 unit will transfer 1 nmol of phosphate/min, using phosphatidylinositol as substrate.